LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.73 | 17.25 | 1166 | 1290 | 0.9037 | 0.9677 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.73 | 17.25 | 1404 | 1290 | 1.0882 | 1.0273 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.70 | 17.25 | 11 | 1466 | 0.0075 | -0.0678 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.70 | 17.25 | 1374 | 1466 | 0.9368 | 0.9797 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.70 | 17.25 | 1291 | 1466 | 0.8802 | 0.9606 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.70 | 17.25 | 1486 | 1466 | 1.0131 | 1.0041 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 28.67 | 17.25 | 16 | 1653 | 0.0097 | -0.0114 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 28.67 | 17.25 | 1518 | 1653 | 0.9183 | 0.9743 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 28.67 | 17.25 | 1373 | 1653 | 0.8305 | 0.9444 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 28.67 | 17.25 | 1585 | 1653 | 0.9588 | 0.9873 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.64 | 17.25 | 21 | 1887 | 0.0111 | 0.0295 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.64 | 17.25 | 1636 | 1887 | 0.8668 | 0.9582 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.64 | 17.25 | 1531 | 1887 | 0.8112 | 0.9392 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.64 | 17.25 | 1727 | 1887 | 0.9150 | 0.9739 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.61 | 17.25 | 19 | 2136 | 0.0089 | 0.0140 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.61 | 17.25 | 1728 | 2136 | 0.8089 | 0.9399 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.61 | 17.25 | 1684 | 2136 | 0.7883 | 0.9327 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.61 | 17.25 | 1890 | 2136 | 0.8847 | 0.9651 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.57 | 17.25 | 8 | 2523 | 0.0032 | -0.1013 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.57 | 17.25 | 1854 | 2523 | 0.7348 | 0.9161 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.57 | 17.25 | 1858 | 2523 | 0.7364 | 0.9167 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.57 | 17.25 | 2012 | 2523 | 0.7974 | 0.9380 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.54 | 17.25 | 4 | 2679 | 0.0015 | -0.1819 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.54 | 17.25 | 2024 | 2679 | 0.7553 | 0.9244 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.54 | 17.25 | 1994 | 2679 | 0.7441 | 0.9204 | MN20160310_N02 | N04 |